ARPIM Criticises Health Ministry's Withdrawal Of Two Draft Bills


News: The Romanian Association of International Medicine Manufacturers (ARPIM) has criticised health ministry's withdrawal of two draft bills concerning the healthcare sector. ARPIM has stated that the withdrawal of two draft bills on the reimbursement budget for medicines and medicine prices will have a negative impact on healthcare reforms in Romania. The first draft bill would have led to an 8% increase in the country's medicine reimbursement budget for H214, according to ARPIM's President Calin Galaseanu. The proposed rise in the reimbursement budget was closer to patients' actual treatment requirements, which would have increased the number of patients that can be treated, Galaseanu added. He stated: 'The second draft bill regarding the pricing mechanism would have represented a positive signal in ensuring the availability of drugs on the Romanian market', reports business-review.eu.

This article is tagged to:
Related sectors of this article: Pharmaceuticals & Healthcare, Regulatory - Pharmaceuticals & Healthcare, Healthcare, Pricing/Reimbursement
Geography: Romania